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Abstract
Background: Clinical guidelines for single diseases often pose problems in general practice work with multimorbid
patients. However, little research focuses on how general practice is affected by the demand to follow multiple
guidelines. This study explored Norwegian general practitioners’ (GPs’) experiences with and reflections upon the
consequences for general practice of applying multiple guidelines.
Methods: Qualitative focus group study carried out in Mid-Norway. The study involved a purposeful sample of 25
Norwegian GPs from four pre-existing groups. Interviews were audio-recorded, transcribed and analyzed using
systematic text condensation, i.e. applying a phenomenological approach.
Results: The GPs’ responses clustered around two major topics: 1) Complications for the GPs of applying multiple
guidelines; and, 2) Complications for their patients when GPs apply multiple guidelines. For the GPs, applying
multiple guidelines created a highly problematic situation as they felt obliged to implement guidelines that were
not suited to their patients: too often, the map and the terrain did not match. They also experienced greater insecurity
regarding their own practice which, they admitted, resulted in an increased tendency to practice ‘defensive medicine’.
For their patients, the GPs experienced that applying multiple guidelines increased the risk of polypharmacy, excessive
non-pharmacological recommendations, a tendency toward medicalization and, for some, a reduction in quality of life.
Conclusions: The GPs experienced negative consequences when obliged to apply a variety of single disease
guidelines to multimorbid patients, including increased risk of polypharmacy and overtreatment. We believe
patient-centered care and the GPs’ courage to non-comply when necessary may aid in reducing these risks.
Health care authorities and guideline developers need to be aware of the potential negative effects of applying
a single disease focus in general practice, where multimorbidity is highly prevalent.
Keywords: General practitioners, Clinical practice guidelines, Guideline adherence, Multimorbidity, Overtreatment,
Patient-centered care, Polypharmacy, Qualitative research, Focus groups
Background
General practitioners (GPs) provide care for any health
problems patients might have and general practice is
regarded as a cornerstone of the health care systems of
many countries. Clinical guidelines build on Evidence-
Based Medicine (EBM) and are designed to improve the
quality of health care and reduce unwanted variations
[1]. If GPs do not follow guidelines as delineated, treat-
ments proven by research to be effective will not benefit
the population at large, thus posing a challenge both to
society and health authorities. The Directorate of Health,
the executive agency in Norway tasked with formulating
national clinical guidelines, categorizes their recommen-
dations primarily according to the GRADE system [2].
It is well known that adherence to clinical guidelines
in general practice is low [3]; most clinical guidelines are
designed for the treatment of single diseases while an in-
creasing amount of research has documented that guide-
lines for single diseases are of little use in the treatment
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of patients with multimorbidity [4, 5]. Multimorbidity is
frequently encountered in general practice, affecting as
many as 23 % of the Scottish [6] and 42 % of the adult
Norwegian populations [7]. Treating multimorbid pa-
tients involves meeting a variety of challenges, only one
of which is that guidelines have been created for the
treatment of single diseases [8, 9].
Overtreatment is defined as unnecessary health care
and has been shown to be highly problematic, both for
multimorbid patients and for patients with single, long-
standing conditions or risk factors [10, 11]. The reasons
for overtreatment seem multifactorial and complex.
Questions arise as to the extent to which multiple
guidelines are drivers of overtreatment [12]. Boyd et al.
documented that adherence to all guidelines simultan-
eously for a hypothetical multimorbid 79-year-old
woman with five different chronic conditions would result
in the prescribing of 12 different medications as well as the
recommending of a complex, non-pharmacological regi-
men [13].
In a previous paper, we documented that GPs offered
compelling reasons for low adherence to clinical guide-
lines, despite considering them necessary [14]. One of
the main explanations was the mismatch they experi-
enced when caring for the whole patient while using
guidelines focused on single diseases [14]. Caring for
the whole person rather than just the single disease is a
well-known characteristic of general practice [15].
Nonetheless, GPs are expected to implement a variety
of clinical guidelines simultaneously, each of which was
designed for the treatment of a single disease. Adher-
ence to guidelines is mandated by medical regulations
in Norway [16]. The failure to follow guidelines for
each single disease has sometimes resulted in practi-
tioners’ work being subjected to professional review.
Despite the gap between clinical practice and guide-
lines being well known, little research focuses on how
general practice is affected by the demand to follow mul-
tiple guidelines [17]. The aim of this study was to ex-
plore Norwegian GPs’ experiences with and reflections
upon the consequences of guidelines for themselves and
their patients, particularly multiple guidelines each de-
signed for the treatment of a single disease.
Methods
Research design, recruitment and sampling
We chose a qualitative design as this is regarded as the
best way to explore and provide rich descriptions of a
complex phenomenon [18, 19]. The theoretical frame-
work we used is phenomenology, a philosophy and
methodology that relies on first-person accounts as a
source of knowledge [20, 21]. We chose to hold focus
group interviews with pre-existing GP groups under the
assumption that their familiarity with each other would
allow the participants to reflect more openly [22]. The
Norwegian Continuing Medical Education (CME) orga-
nizes groups of GPs who are working towards fulfilling
the mandatory requirements of specialist training in
general practice (junior groups) and registers self-
selected groups whose members have already completed
their specialization (senior groups) [23]. In Norway, par-
ticipation in a senior group is a requirement for main-
taining one’s status as specialist. Utilizing the CME
system allowed us to have an overview of the existing
local groups that we could approach. For reasons of con-
venience, we invited groups from only one region of the
country, Mid-Norway, to participate. To ensure a stra-
tegic, purposeful sample of GPs with a spread of age and
work experience, we approached two junior groups and
two senior groups and planned to include more groups
if the material was not saturated. All four groups agreed
to participate.
Interview settings
In 2013, each group was interviewed once at the location
where they usually met. Three groups met at medical
centers while one met at another meeting room. The in-
terviews lasted 60–90 min. Two researchers participated
in all the interviews, one as a moderator and the other
as an assistant. The moderator (BA) ensured that all par-
ticipants participated in the discussion and also facili-
tated the elaboration of their varying opinions and views.
As well as posing some questions, the assistant (BPM or
HTB – see Acknowledgments) was responsible for the
audio-recordings and the notation of the order of speech.
The interviews started with the moderator reading
from a Norwegian article that problematized applying
disease-specific clinical guidelines in the treatment of
multimorbid and elderly patients in general practice
[24]. The groups were asked what they thought about
the article and whether it was recognizable from their
clinical practices. The interview guide included the fol-
lowing main themes: 1) use of clinical guidelines in their
daily practice; 2) use of clinical guidelines with multi-
morbid patients; 3) guideline characteristics that might
facilitate or hinder GPs’ adherence; and, 4) guidelines as
quality assurance in clinical practice. The questions were
open-ended and the order flexible. Topics concerning
the complications created for general practice by apply-
ing multiple clinical guidelines arose spontaneously dur-
ing all the interviews and were then further explored.
The group interviews were audio-recorded and tran-
scribed verbatim.
Analysis and interpretation
To analyze the data, we used ‘systematic text condensa-
tion’, a thematic cross-case analysis based on Giorgi’s
phenomenological analysis [25, 26]. It consisted of the
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following steps: 1) reading and listening to all the mater-
ial and obtaining an overall impression; 2) identifying
‘meaning units’, units of text providing knowledge of
the phenomenon being studied, and then sorting and
coding them; 3) condensing and abstracting the mean-
ing within each of the coded groups; and, 4) synthesiz-
ing the condensations into major topics and sub-topics
that reflected the GPs’ experiences of how following
multiple clinical guidelines affected general practice. All
the authors participated in the analysis and interpretation
of the data. All the authors have clinical experience as ei-
ther GPs (BA, BPM, and IH) or as a nurse (ASH), and all
four are also university researchers and educators.
Results
Participant characteristics are listed in Table 1. While
our aim was to explore the consequences of applying
multiple guidelines, the GPs’ interview responses to our
open-ended questions clustered spontaneously around
complications. We categorized the results into: 1) Com-
plications for the GPs of applying multiple guidelines;
and, 2) Complications for their patients when GPs apply
multiple guidelines. We sub-divided those two topics
into the sub-topics elaborated below.
Complications for the GPs of applying multiple guidelines
A highly problematic situation
Some guidelines were experienced as contributing to
safety and aiding the GPs in choosing treatments. None-
theless, attempts to adhere to the combined total of all
applicable clinical guidelines resulted in the GPs feeling
they lost the overview over the relevant recommenda-
tions, which in turn increased their frustration and a
tendency to give up on guidelines altogether. The GPs
experienced the situation to be highly problematic. As
one GP said:
When you have so many chronic diseases and are
expected to follow all the guidelines – the result is
chaos. (Group 1, M4)
They asserted that, despite clinical guidelines designed
for the treatment of single diseases being of little value
when treating multimorbid patients, the GPs still felt
themselves to be under pressure to attempt to adhere to
all of them – even when, as they put it, the map and the
terrain simply did not match. In the following quote,
one GP reflects over the shortcomings of clinical guide-
lines in relation to complex medical histories.
There are no guidelines yet which can encompass
‘complexity-based medicine’. To grasp how to work
with the complexity we confront as GPs requires a
massive, theoretical quantum leap. Perhaps in 10–15
years we will realize that all of today’s reductionist
guidelines within the natural sciences were wrong and
had led us astray. (Group 2, M7)
Increased insecurity
Some GPs experienced a growing insecurity as to whether
or not their own clinical practice was in accordance with
the guidelines. One claimed that if someone were to
look systematically at perhaps 100 patient records from
each of the GPs in the focus group, mistakes would
probably be found in all of them. The total number of
demands in the guidelines was simply impossible to
meet. This created insecurity.
The insecurity that a ‘guideline hell’ brings is negative,
but that is not talked about very often. (Group 2, M7)
Some of the senior GPs did not feel less secure. One,
who was close to retirement age, said that he did not
worry anymore about any professional review proce-
dures. However, regardless of how long they had been in
practice, most of the GPs hoped to avoid being subjected
to licensing review. They feared that the monitoring au-
thorities would evaluate their work based solely on what
they should have done according to existing guidelines,
without taking their clinical judgement into consideration.
More ‘defensive medicine’
The fear of criticism or of being subjected to profes-
sional review for failing to adhere to guidelines seems to
have led to GPs practicing more ‘defensive medicine’,
such as increasing their prescribing of drugs and making
Table 1 Characteristics of the study participants
Group 1 (n = 7) Group 2 (n = 8) Group 3 (n = 3) Group 4 (n = 7) Total (n = 25)
Female (n) 3 2 0 5 10
Age in years min – max (mean) 31 – 39 (34.3) 45 – 62 (55.9) 40 – 47 (44.3) 31 – 45 (37.0) 31 – 62 (43.4)
Years as GPa min – max (mean) 1 – 4 (2.9)a 8 – 35 (22.6) 12 – 13 (12.3) 0 – 4 (2.4)a 0 – 35 (9.6)
Specialist in general practice (n) 0 8 3 0 11
Specialist in another medical discipline (n) 1 1 0 1 3
aYears of experience in open, unselected general practice. Two of the participants with the least experience as GPs had 5–6 years of experience in an
Emergency Ward
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more referrals to specialists than they actually thought
were necessary. As one GP put it:
I often chose to ‘protect my back’ by doing too much,
by following up too thoroughly, for instance, ordering
additional x-rays or other extra examinations.
(Group 4, K10)
Another participant pointed out that GPs are rarely if
ever subjected to professional review for overtreatment.
We never get criticized for doing too much. You don’t
get in trouble for having initiated unnecessary
examinations even if they lead to complications. But
you can be sure you’ll get in trouble if you haven’t
done enough! We’re much more vulnerable to the
entire health care system’s expectation that things
must be done. There’s an intense ‘action imperative’
to do more. (Group 2, M7)
Keeping thorough patient records seems to be another
way the GPs guarded themselves, especially when they
knew they had deviated from the guidelines.
When I deviate from the guidelines, I am careful
to write my reasons down in the patient record.
For instance, if I take a patient off acetylic acid
because he developed a stomach ulcer, I write that I
am aware of the increased risk of a blood clot. Good
record-keeping helps protect me. (Group 3, M11)
Complications for their patients when GPs apply
multiple guidelines
Excessive pharmacological and non-pharmacological
treatment
Most guidelines include recommendations for medical
treatments for diseases and risk factors. The GPs claimed
polypharmacy to be a widespread problem for many of
their patients, especially the elderly and multimorbid, and
they worried that adhering to multiple guidelines might
exacerbate that tendency.
It’s great that there are guidelines, and I try to follow
them. But when the patients have several diseases,
there are too many guideline recommendations.
Especially when patients are getting older, how much
medicine should you give them? (Group 3, M12)
Polypharmacy was considered problematic as it could
result in side effects and/or drug interactions while the
actual benefit to the individual patient might remain
questionable. One participant stated that GPs have a
responsibility to counteract polypharmacy. However,
several reported difficulty discontinuing medications,
especially if a specialist had initiated the treatment.
I see how patients go into the hospital and have new
medications added because the hospital has followed
the guidelines. We often have to take responsibility later
for having the patients discontinue some meds and we
thereby ‘break the rules’. That’s no easy job! But we have
to try to see the whole patient. (Group 4, K9)
Some guidelines include non-pharmacological recom-
mendations. The GPs experienced that some of these
proved too time-consuming to follow up on for many of
the patients – in some cases, even completely unrealis-
tic. As a result, the GPs tried to individualize the recom-
mendations, to tailor them to the patients’ needs rather
than adhere to them exactly as stated.
The treatment must be planned, individually, based
on the patient's functional ability, interests, what he
actually manages to follow up on in everyday life,
how many activities he can tolerate during a week.
The non-pharmacological regimen should not place
an additional burden on people already struggling
with chronic diseases. (Group 4, K6)
Increased medicalization
The existing guidelines refer to criteria for disease def-
inition, some of which have changed over time. The
GPs had experienced treating several patients diag-
nosed with diabetes and hypertension after such
changes of definitions were made. They also described
a growing trend wherein complaints previously con-
sidered to be common ailments might now be
regarded as diseases that physicians were obligated to
treat. They were concerned that an increased tendency
toward medicalization might result from increasing
the percentage of the population that multiple guide-
lines now defined as being at risk.
It seems to me as if some of the guidelines’
recommendations are implying: Everybody needs
treatment, but so many people just don’t know it yet.
We GPs have to counteract this and let our patients
know that we don’t think they’ll live any longer or
have a better life if we just put them on one additional
drug. (Group 2, M6)
Reduced quality of life
The GPs shared stories about overly-extensive pharma-
cological and/or non-pharmacological treatments having
contributed to a reduction in quality of life for some of
their multimorbid patients. Even though longstanding
chronic diseases were considered important to treat and
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follow up, dilemmas arose when guidelines recom-
mended treatments that the GPs meant did not benefit
the patients’ overall situation or quality of life.
A patient of mine with atrial fibrillation, COPD and
heart failure is often hospitalized because of dizziness.
The cardiologists treat him every time with a beta
blocker, in accordance with the guidelines, but he gets
bradycard, so I deprescribe it after every hospital stay.
Seen in isolation, he could conceivably benefit from
being on that medication, but he does not tolerate it.
I regulate treatment according to the patient’s
symptoms and overall situation. (Group 4, M14)
In addition, the GPs experienced that the guidelines
did not take into account their patients’ varying attitudes
towards treatment and taking medications.
What matters most is the patients’ quality of life.
We as GPs have to listen to what the patients say,
and do the best we can to relieve their suffering.
(Group 3, M13)
Discussion
Summary of the main findings
For the GPs, the obligation to apply multiple guidelines
each of which was designed to treat single diseases cre-
ated various complications. They found it highly prob-
lematic to be required to implement guidelines that did
not fit their patients, when the map and the terrain
simply did not match. They also experienced greater in-
security about their own practice which, they admitted,
increased the tendency to practice ‘defensive medicine’.
The complications for their patients which the GPs ex-
perienced when applying multiple guidelines included
an increased risk of polypharmacy, of excessive non-
pharmacological recommendations, an increased ten-
dency toward medicalization and a potentially reduced
quality of life.
Strengths and limitations of the study
Diversity is considered a strength in qualitative studies
[27]. Although all participants worked in Mid-Norway
(Table 1), our sample of 25 GPs was diverse as regards
work experience as well as demographic variables such
as age and gender. Otherwise, the participants did not
differ systematically from Norwegian GPs as a group
[28]. When we realized shortly before one of the focus
group sessions that only three participants would be
available to attend, we considered choosing a different
group. We decided not to cancel the interview and,
despite the small number of participants, the discussion
that ensued proved to be so rich that we included the
data in our material. After conducting four focus
groups, we carried out critical readings of the tran-
scripts and determined that the material was suffi-
ciently saturated. As we only interviewed the GPs, all
the descriptions of the complications for their patients
of following multiple guidelines were from the GPs’
point of view, not that of the patients themselves.
Nevertheless, we consider the GPs’ perceptions to be
reliable since they work closely with their patients and
are trained to observe how their patients react to med-
ical advice and treatment.
The study was conducted in Norway where national
clinical guidelines are provided by the health author-
ities and adherence is regulated. This may limit how
transferable some of our findings might be to countries
following different approaches to the development, im-
plementation and regulation of clinical guidelines.
The fact that the moderator was a GP can be consid-
ered both as a strength and a limitation. Talking to a
member of their own profession and presuming a com-
mon understanding of clinical work may have helped
the participants speak more openly. On the other hand,
the participants might have wanted to ‘comfort’ the
moderator, and consequently downplayed important
contradictory views or nuances. To address this poten-
tial limitation, we attempted to make our preconcep-
tions overt, to ask open-ended questions and encourage
contradicting views. All authors also evaluated the
interview guide and the results critically. Our experi-
ence was that the moderator being a GP facilitated the
disclosure of whatever disagreements existed among
the participants.
We began each of the interviews by reading from an
article that we presumed would awaken the GPs’ aware-
ness of their experiences with adhering to multiple
guidelines and stimulate them to reflect on the conse-
quences [24]. The article did not seem to arouse contro-
versy; most of the GPs recognized the patient story in it
from their own practice. Conceivably, this way of open-
ing the focus group interviews may have influenced the
participants to respond more critically to the conse-
quences of multiple guidelines than they actually were.
However, we think the participants’ familiarity with each
other helped them to feel safe enough to disagree, both
with the article and with each other. This added variety
and enriched the complexity of our material.
Implications of the findings in context of existing
research
Guidelines as drivers of overtreatment
In recent years, the international focus on overtreat-
ment and overdiagnosis has increased, especially con-
cerning multimorbid and elderly patients [29, 30]. The
British Medical Journal’s series entitled, “Too Much
Medicine”, and The Journal of the American Medical
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Association’s, “Less is More”, are examples of this
increased focus [31, 32]. The following statement was
made at the 2013 international scientific conference,
‘Preventing Overdiagnosis’: “Overdiagnosis harms people
worldwide and exacerbates undertreatment by wasting
much needed resources” [33]. Still, the definition of over-
diagnosis is not clear and the controversy regarding the
extent of the problem continues [34]. The GPs in
the present study expressed that, despite their intent
to avoid overtreatment, polypharmacy and the rec-
ommendation of more treatment than they actually
deemed necessary, these tendencies represented a
widespread problem for their patients. This would
indicate that overtreatment is a challenge for Norwe-
gian general practice.
Overtreatment seems to be multifactorial and com-
plex, and several drivers have been identified [35, 36].
One of the drivers which we identified in our interviews
with the GPs was the obligation to implement multiple
guidelines each designed to treat single diseases when
treating multimorbid patients and patients with a variety
of risk factors. This finding is supported in other studies
criticizing clinical guidelines for extending disease defi-
nitions and thus introducing treatment to a larger seg-
ment of the population [37, 38].
At the same time, the expressed intention of clinical
guidelines is not to provoke overtreatment but to help
in offering patients the best treatment possible. Some
guidelines include recommendations for when to
refrain from offering treatment; others state specific-
ally that guidelines are only to be considered supple-
mentary to clinical judgement [39, 40]. Also, some
multimorbid patients need several medications [41].
However, in our findings, GPs’ expressed concern
about the need to safeguard themselves legally, pre-
scribing medication in order to ‘cover their back’
rather than because they considered it medically ne-
cessary for the patient. This indicates how difficult the
pressure to adhere to guidelines can be to manage in
actual practice. This finding is supported by an article
in the BMJ that questions whether we have given
guidelines too much power [42]. Also, the fact that the
Norwegian health authorities expect GPs to follow na-
tional guidelines might increase the pressure to adhere
to multiple guidelines simultaneously, and thereby
contribute to overtreatment [16].
Evidence-based medicine in general practice
Clinical guidelines build on EBM and are most often
designed to treat single diseases or risk factors [43].
Documentation of the effectiveness of prescribed medi-
cation is essential also within general practice. Prob-
lems arise, however, and the complexity increases for
both the GP and the patient, when several treatments
are applied to the same person [44]. There is very lim-
ited empirical evidence regarding the effects of mixing
medications since they are usually studied one at a time.
It is well known that a single disease focus does not seem
to function as intended in primary care [45, 46]. The rea-
sons for this have been highly debated with both too much
and too little application of EBM being criticized [47].
A literature review of NICE guidelines relating to pri-
mary care documented that nearly two-thirds of the
publications cited were of uncertain relevance to pa-
tients in primary care, and some have claimed EBM to
be a movement in crisis [48, 49]. Questions have also
been raised as to whether the lacking success of guide-
lines is implicit within the traditional, biomedical model
in which people are treated as if they were advanced,
biological clock-works [50, 51].
One Irish study documented that GPs make compro-
mises between patient-centered care and care based on
EBM in the management of multimorbid patients [52].
In our study, the GPs expressed that the obligation to
implement multiple guidelines designed for treating sin-
gle diseases that did not benefit the patients’ overall
health or quality of life left them in a highly problematic
and chaotic situation. Focus on the whole patient rather
than single diseases is a well-known characteristic of
general practice. In their definition of general practice,
the European section of the World Organization of
Family Doctors (Wonca Europe) states that patient-
centered care is a key feature [53]. One of Barbara Star-
field’s four main features of primary care was: “long-term
person- (not disease) focused care” [54]. The patient-
centered model, as opposed to the doctor-centered model,
ascribes more value to the presented problem of the pa-
tient and less to single diseases [17]. This model chal-
lenges the disease focus found in clinical guidelines,
and thereby also the biomedical research on which the
guidelines are based. Working in a patient-centered
way in general practice, we believe, can contribute to coun-
teracting some of the tendency toward overtreatment.
Conclusions
The GPs’ experienced various negative consequences
when adhering to multiple guidelines designed to treat
single diseases, including their acting as a driver for
polypharmacy and overtreatment. Adherence to clinical
guidelines for treating single diseases was experienced as
incompatible with a patient-centered approach to the
treatment of patients with multimorbidity; the map and
the terrain did not match.
This study contributes to a critique of the paradigm
in which ‘best practice’ is based on clinical guidelines
and biomedical research for single diseases or frag-
ments. As long as most of the health care system re-
mains deeply rooted in this paradigm, designing an
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‘alternative’ approach will remain a difficult task, one
that clearly exceeds the scope of this study. Still, we be-
lieve patient-centered care and the GPs’ courage to
non-comply when necessary can serve as countermea-
sures to prevent overtreatment. Health care authorities
and guideline developers need to be aware of the po-
tential negative effects of single disease focus in general
practice, where multimorbidity is highly prevalent.
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